Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 14Prostatic Neoplasms 4Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Precancerous Conditions 2Peripheral Nervous System Diseases 2Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Breast Carcinoma In Situ 2Weight Loss 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma × Fatty Acids, Omega-3 × Clear all
NCT00003077 2016-07-13

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Alliance for Clinical Trials in Oncology

Phase 1/2 Completed
63 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡